Roche (OTCMKTS:RHHBY) Stock Acquired Rep. Bruce Westerman

Representative Bruce Westerman (R-Arkansas) recently bought shares of Roche Holding AG (OTCMKTS:RHHBY). In a filing disclosed on April 16th, the Representative disclosed that they had bought between $1,001 and $15,000 in Roche stock on March 3rd. The trade occurred in the Representative’s “FISHER IRA” account.

Representative Bruce Westerman also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of LVMH Moët Hennessy – Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) on 4/2/2025.
• Purchased $1,001 – $15,000 in shares of Sony Group (NYSE:SONY) on 3/24/2025.
• Purchased $1,001 – $15,000 in shares of Mitsubishi UFJ Financial Group (NYSE:MUFG) on 3/21/2025.
• Purchased $1,001 – $15,000 in shares of BP (NYSE:BP) on 3/21/2025.
• Sold $1,001 – $15,000 in shares of Procter & Gamble (NYSE:PG) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of Medtronic (NYSE:MDT) on 3/20/2025.
• Purchased $1,001 – $15,000 in shares of ASML (NASDAQ:ASML) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of Visa (NYSE:V) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 3/20/2025.

Roche Stock Up 0.8 %

OTCMKTS RHHBY opened at $38.90 on Friday. Roche Holding AG has a 1-year low of $29.20 and a 1-year high of $44.31. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86. The stock’s 50 day moving average is $40.93 and its two-hundred day moving average is $38.55.

Hedge Funds Weigh In On Roche

A number of large investors have recently modified their holdings of RHHBY. Brooklyn Investment Group lifted its holdings in Roche by 36.6% during the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after buying an additional 363 shares in the last quarter. Verity Asset Management Inc. raised its position in shares of Roche by 26.8% during the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock worth $280,000 after acquiring an additional 1,697 shares during the last quarter. HighPoint Advisor Group LLC lifted its stake in shares of Roche by 2.8% during the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock valued at $387,000 after acquiring an additional 304 shares during the period. Fulton Bank N.A. boosted its holdings in Roche by 2.6% in the first quarter. Fulton Bank N.A. now owns 12,620 shares of the company’s stock valued at $518,000 after acquiring an additional 314 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in Roche by 59.5% in the first quarter. GAMMA Investing LLC now owns 12,850 shares of the company’s stock worth $529,000 after purchasing an additional 4,794 shares during the period.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on RHHBY. Morgan Stanley started coverage on Roche in a research report on Wednesday, February 12th. They issued an “equal weight” rating on the stock. Sanford C. Bernstein upgraded shares of Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Finally, UBS Group upgraded shares of Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 13th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

About Representative Westerman

Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas’ 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.

Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas’ 4th Congressional District. He declared candidacy for the 2026 election.

Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.